{"authors": [["Cohen", "R", "R", "Groupe de Pathologie Infectieuse P\u00e9diatrique (GPIP) de la Soci\u00e9t\u00e9 fran\u00e7aise de p\u00e9diatrie, Saint Maur des Foss\u00e9s, France; ACTIV (Association Clinique et Th\u00e9rapeutique Infantile du Val de Marne), 27 rue Inkermann, 94100 Saint-Maur des Foss\u00e9s, France; Universit\u00e9 Paris Est, IMRB- GRC GEMINI, 94000 Cr\u00e9teil, France; Centre de Recherche Clinique (CRC) et Centre Hospitalier Intercommunal (CHI), 40 avenue de Verdun, 94010 Cr\u00e9teil, France; Unit\u00e9 Court S\u00e9jour, Petits Nourrissons, Service de N\u00e9onatologie, Centre Hospitalier Intercommunal de Cr\u00e9teil (CHI), 40 avenue de Verdun, 94010 Cr\u00e9teil, France. Electronic address: robert.cohen@wanadoo.fr."], ["Raymond", "J", "J", "Groupe de Pathologie Infectieuse P\u00e9diatrique (GPIP) de la Soci\u00e9t\u00e9 fran\u00e7aise de p\u00e9diatrie, Saint Maur des Foss\u00e9s, France; Universit\u00e9 Paris Descartes, H\u00f4pital Cochin, Service de Bact\u00e9riologie, Paris, France."], ["Hees", "L", "L", "Groupe de Pathologie Infectieuse P\u00e9diatrique (GPIP) de la Soci\u00e9t\u00e9 fran\u00e7aise de p\u00e9diatrie, Saint Maur des Foss\u00e9s, France; H\u00f4pital Femme M\u00e8re Enfant Service des Urgences P\u00e9diatriques, 69 Bd Pinel 69677 Bron, France."], ["Pinquier", "D", "D", "Groupe de Pathologie Infectieuse P\u00e9diatrique (GPIP) de la Soci\u00e9t\u00e9 fran\u00e7aise de p\u00e9diatrie, Saint Maur des Foss\u00e9s, France; P\u00f4le Femme-M\u00e8re-Enfant, P\u00e9diatrie N\u00e9onatale et R\u00e9animation, H\u00f4pital Charles Nicolle, CHU Rouen, France; IHU Recherche Biom\u00e9dicale ; EA4309, Universit\u00e9 de Rouen, France."], ["Grimprel", "E", "E", "Groupe de Pathologie Infectieuse P\u00e9diatrique (GPIP) de la Soci\u00e9t\u00e9 fran\u00e7aise de p\u00e9diatrie, Saint Maur des Foss\u00e9s, France; Universit\u00e9 Pierre & Marie Curie, Paris 6, France; Service de p\u00e9diatrie g\u00e9n\u00e9rale et aval des urgences, H\u00f4pital Armand-Trousseau, Paris, France."], ["Levy", "C", "C", "Groupe de Pathologie Infectieuse P\u00e9diatrique (GPIP) de la Soci\u00e9t\u00e9 fran\u00e7aise de p\u00e9diatrie, Saint Maur des Foss\u00e9s, France; ACTIV (Association Clinique et Th\u00e9rapeutique Infantile du Val de Marne), 27 rue Inkermann, 94100 Saint-Maur des Foss\u00e9s, France; Universit\u00e9 Paris Est, IMRB- GRC GEMINI, 94000 Cr\u00e9teil, France; Centre de Recherche Clinique (CRC) et Centre Hospitalier Intercommunal (CHI), 40 avenue de Verdun, 94010 Cr\u00e9teil, France."]], "date": null, "id": "29290234", "text": "The implementation of pneumococal conjugate vaccines (PCVs) 7 then 13 valent (Prevenar13\u00ae) in 2010-2011 has significantly changed the profile of pneumococcal meningitis. Since 3 years, the National Pediatric Meningitis Network of the Pediatric Infectious Disease Group (GPIP) and the National Reference Centre of Pneumococci have reported no cases of meningitis due to pneumococcus resistant to third-generation cephalosporins (3GC): cefotaxime or ceftriaxone. In the light of these new data, vancomycin should no longer be prescribed at the initial phase of pneumococcal meningitis treatment (confirmed or only suspected) and this antibiotic should only be added when 3GC minimum inhibitory concentration of the strain isolated is greater than 0.5mg/L. For meningococcal meningitis, nearly 20% of strains have decreased susceptibility to penicillin and amoxicillin, but all remain susceptible to 3GC. The National Pediatric Meningitis Network is a valuable tool because it has been sufficiently exhaustive and sustainable over 15 years. Maintaining this epidemiologic surveillance will allow us to adapt, if necessary, new regimens for subsequent changes that could be induced by vaccination and/or antibiotic uses.", "doi": "10.1016/S0929-693X(17)30518-3", "title": "Bacterial meningitis antibiotic treatment.", "journal": ["Archives de pediatrie : organe officiel de la Societe francaise de pediatrie", "Arch Pediatr"]}